儿童创伤复苏中血液制品比例与早期死亡的关系:基于国家创伤数据库的时间依赖分析
该研究基于2017–2019年创伤质量改进项目数据库,纳入1,152例接受大容量输血的创伤患儿(中位年龄15岁,32%为穿透伤,28%合并严重创伤性脑损伤),以15分钟为间隔分配血液制品组,采用含时间依赖变量的Cox模型分析24小时死亡率。结果显示,各血液制品组间死亡率无显著差异;在严重创伤性脑损伤患儿中,高血浆/红细胞比例但未输注血小板组的死亡风险较高血浆/红细胞比例联合血小板组有降低趋势(HR 0.55,p=0.07)。作者认为,平衡复苏策略(尤其是血小板输注)对严重创伤性脑损伤患儿可能影响最大,优化儿童平衡复苏需精心设计的前瞻性研究。
要点
- 在1,152例接受大容量输血的创伤患儿中,24小时死亡率为18%。
- 将血液制品组作为时间依赖变量纳入Cox模型后,高比例或全血与死亡率无显著关联。
- 严重创伤性脑损伤患儿中,高血浆/红细胞比例但未输注血小板组较高血浆/红细胞比例联合血小板组死亡风险有降低趋势(HR 0.55,p=0.07)。
- 复苏期间患者可更换血液制品组多达6次,高比例组患者数量随时间增加。
- 作者认为,平衡复苏策略(特别是血小板输注)对严重创伤性脑损伤患儿可能影响最大。
适用人群与场景
- 2017至2019年创伤质量改进项目数据库中,年龄小于18岁、接受大容量输血(最初4小时内总制品>40 mL/kg或>2 U浓缩红细胞或全血)的创伤患者。
诊断标准与关键阈值
- 大容量输血定义:最初4小时内总制品>40 mL/kg或>2 U浓缩红细胞或全血。
研究设计与关键结果
- 研究类型:基于国家创伤数据库的时间依赖分析;样本量1,152例;中位年龄15岁;32%为穿透伤,28%合并严重创伤性脑损伤;18%在24小时内死亡。
- 以15分钟为间隔将患者分配至血液制品组:高血浆/红细胞比例(>1:1)联合血小板、高血浆/红细胞比例(>1:1)未联合血小板、低血浆/红细胞比例(<1:1)、仅浓缩红细胞、全血。
- 复苏期间高比例组患者数量随时间增加,患者更换血液制品组多达6次。
- 各血液制品组间死亡率无显著差异。
- 严重创伤性脑损伤患儿中,高血浆/红细胞比例未联合血小板组较高血浆/红细胞比例联合血小板组死亡风险有降低趋势(HR 0.55,p=0.07)。
证据类型、等级与局限
- 证据类型:基于创伤质量改进项目数据库的时间依赖分析;证据等级:治疗/管理,Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,平衡复苏策略(特别是血小板输注)对严重创伤性脑损伤患儿可能影响最大;优化儿童平衡复苏需精心设计的前瞻性研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Injured children with severe hemorrhage often receive blood product transfusions with ratios of plasma and platelets to packed red blood cells (PRBCs) approaching 1:1:1. Whether blood product ratios vary during pediatric resuscitation is unknown. This study (1) described precise timing of pediatric blood product administration, (2) characterized changes in blood product ratios over time, and (3) evaluated the association of blood products with early mortality while incorporating time-varying factors.
METHODS: Pediatric (younger than 18 years) trauma patients receiving high-volume transfusion (>40 mL/kg total products or >2 U PRBC or whole blood, during first 4 hours) were obtained from the 2017 to 2019 Trauma Quality Improvement Program database. The time of each individual product transfusion was recorded, along with demographics, injury details, and times of death. Patients were assigned to blood product groups at 15-minute intervals: high plasma/PRBC ratio (>1:1) with platelets, high plasma/PRBC ratio (>1:1) without platelets, low plasma/PRBC ratio (<1:1), PRBC only, and whole blood. Cox proportional hazards modeling for 24-hour mortality was performed, including blood product group as a time-varying variable and adjusting for relevant covariates.
RESULTS: Of 1,152 included patients (median age, 15 years; 32% penetrating, 28% severe traumatic brain injury [sTBI]), 18% died within 24 hours. During the resuscitation period, the number of patients in high-ratio groups increased over time, and patients switched blood product groups up to six times. There was no significant difference in mortality by blood product group. Among patients with sTBI, there was a strong trend toward lower mortality among high plasma/PRBC without platelets versus high plasma/PRBC with platelets (hazard ratio, 0.55; p = 0.07).
CONCLUSION: No significant association of high ratios or whole blood with mortality was seen when time-varying factors were incorporated. The impact of balanced resuscitation strategies, particularly platelet transfusion, may be greatest among patients with sTBI. Optimizing balanced resuscitation for children requires appropriately designed prospective studies.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.
参考来源
- Snyder CW, Neff LP, Chandler NM, et al. Association of blood product ratios with early mortality in pediatric trauma resuscitation: A time-dependent analysis from the National Trauma Databank. J Trauma Acute Care Surg. 2023. PMID: 36850027. doi:10.1097/TA.0000000000003905
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。